Mark Iwicki
Net worth: - $ as of 2026-05-30
Net worth: - $ as of 2026-05-30
Mr. Mark T. Iwicki is a Chairman at Q32 Bio, Inc., a Chairman at Akero Therapeutics, Inc., an Independent Director at Pulmatrix, Inc., an Independent Non-Executive Director at Merus NV, a Chairman, President & Chief Executive Officer at Kala Pharmaceuticals, Inc. and an Independent Director at Aimmune Therapeutics, Inc. He is on the Board of Directors at Pulmatrix, Inc., Merus NV, Nimbus Therapeutics LLC, Aimmune Therapeutics, Inc., Nimbus Apollo, Inc., Oxeia Biopharmaceuticals, Inc. and Pulmatrix Operating Co., Inc. Mr. Iwicki was previously employed as a President, Chief Executive Officer & Director by Civitas Therapeutics, Inc., a President, Chief Executive Officer & Director by Blend Therapeutics, Inc., a President & Chief Executive Officer by Sepracor Pharmaceuticals Inc, a Vice President by Novartis Pharmaceuticals Corp., a Vice President & Head-Cardiovascular Business Unit by Novartis Pharmaceuticals UK Ltd., a Principal by Astra Merck, Inc., a Principal by Merck & Co., Inc., and a President & Chief Executive Officer by Sumitomo Dainippon Pharma Co., Ltd. He also served on the board at TARIS BioMedical LLC and Wellesley Youth Hockey Association. He received his undergraduate degree from Ball State University (Indiana) and an MBA from Loyola University Maryland, Inc..
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KALA BIO, INC. -.--% | 2025-12-28 | 0 ( -.--% ) | - $ | 2026-05-30 |
| 2026-04-14 | 0 ( -.--% ) | - $ | 2026-05-30 | |
-.--% | 2026-06-11 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Chairman | 2020-04-30 |
| INHIBIKASE THERAPEUTICS, INC. | Chief Executive Officer | 2025-02-13 |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Chairman | 2020-12-21 |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Director/Board Member | - |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| KALA BIO, INC. | Chief Executive Officer | 2025-02-10 |
| MERUS N.V. | Chairman | 2018-06-30 |
| AKERO THERAPEUTICS, INC. | Chairman | 2025-12-08 |
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 26 |
|---|---|
Sumitomo Pharma Co., Ltd.
Sumitomo Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and other chemical products | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Health Technology |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Health Technology |
Kala Bio, Inc.
Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biotechnology company which develops therapeutics for mild traumatic brain injuries and neuro-metabolic dysfunctions | Health Technology |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Sells pharmaceuticals products | Health Technology |
Ball State University (Indiana)
Ball State University (Indiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University Maryland, Inc.
Loyola University Maryland, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Pulmatrix, Inc.
Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Health Technology |
Wellesley Youth Hockey Association
Wellesley Youth Hockey Association Movies/EntertainmentConsumer Services Operates as an association for the improvement of hockey | Consumer Services |
Akero Therapeutics, Inc.
Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Third Harmonic Bio, Inc.
Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions